Zoledronic Acid FDA Link

An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS.

Also Known As:

Zometa; 2- (Imidazol- 1- yl)- 1- hydroxyethylidene- 1,1- bisphosphonic acid; CGP 42'446; CGP 42446A; CGP-42'446; CGP-42446; Zoledronate; Zoledronic Acid Anhydrous; CGP 42446; CGP42'446; CGP42446

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Diphosphonates: 11565
      - Zoledronic Acid: 3599
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - Zoledronic Acid: 3599

Seizou Yamamoto Selected Research

Seizou Yamamoto Research Topics

Disease

Drug/Important Bio-Agent (IBA)